hepatitis C virus NS3 protease inhibitor (Astex Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehepatitis C virus NS3 protease inhibitor (Astex Therapeutics)
Drug Alias Nameviral enzyme inhibitors (Astex)AT-23708AT-26893
ClassificationSmall molecules
Mechanisms of ActionHepatitis C virus (HCV) nonstructural protein 3 inhibitors
TargetsHepatitis C virus (HCV) nonstructural protein 3
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A